Ouro Medicines Ltd
ActiveData to 4 Nov 2026, 02:03
- Company number
- 16049297
- Sector
- Not in a live sector
- SIC group
- Deep tech and hardware
- Region
- London (Uxbridge)
- Incorporated
- 29 Oct 2024
- SIC code
- 72190
- Trading name
- Not found
- Website
- Not found
Ouro Medicines Ltd has 4 priced rounds on record from share allotment filings at Companies House. The latest was allotted on 19 Feb 2026, raised £7.39m, and was filed on 22 Jun 2026. Data to 3 Nov 2026.
Companies with significant control: Gilead Sciences, Inc. (75 to 100%). From the PSC register.
4
Priced rounds
Allotted Dec 2024 to Feb 2026
£29.8m
Cash raised in those rounds
Sum of sterling cash raised in each round, as filed
19 Feb 2026
Latest round allotted
Filed 22 Jun 2026
Jump to
Funding rounds
Priced equity rounds read from share allotment filings at Companies House, newest first.
| Allotted | First filed | Cash raised | Filing |
|---|---|---|---|
| 19 Feb 2026to 24 Feb 2026Latest | 22 Jun 2026 | £7.39m | Open filing |
| 15 Oct 2025to 20 Nov 2025 | 1 Apr 2026 | £9.80m | Open filing |
| 18 Jul 2025 | 18 Aug 2025 | £3.73m | Open filing |
| 13 Dec 2024to 22 Jan 2025 | 17 Apr 2025 | £8.83m | Open filing |
Companies with significant control
Companies with significant control over Ouro Medicines Ltd, from the register of people with significant control. A company can have control without holding shares. Individuals are not shown on public pages.
| Holder | Notified | Ceased | Shares held |
|---|---|---|---|
| Gilead Sciences, Inc. | 3 Jun 2026 | n/a | 75 to 100% |
From the PSC register.
Filings
No capital filings other than share allotments (SH01) are recorded. 4 share filings (SH01) have been read for this company.
Documents open at Companies House. Bradshaw does not store or re-host them.
About this page
This page shows public register data for Ouro Medicines Ltd. Figures come from filings at Companies House; Bradshaw links to each filing and does not host copies. To correct or object to data about you, use the data request form.
Last updated 3 Nov 2026